These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 16955057)

  • 61. Advances in heart failure: natriuretic peptide testing.
    Rehman SU; Januzzi JL
    Panminerva Med; 2008 Jun; 50(2):139-51. PubMed ID: 18607337
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Early warning system for pulmonary fluid status monitoring in terminal heart failure].
    Wedekind H; Möller K
    Dtsch Med Wochenschr; 2007 Mar; 132(11):555-9. PubMed ID: 17342631
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure.
    Masson S; Latini R
    Am J Cardiol; 2008 Feb; 101(3A):56-60. PubMed ID: 18243860
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Brain natriuretic peptide in heart failure.
    Aronow WS
    J Am Geriatr Soc; 2006 Feb; 54(2):368-9; author reply 369. PubMed ID: 16460396
    [No Abstract]   [Full Text] [Related]  

  • 66. Current understanding of biochemical markers in heart failure.
    Sato Y; Miyamoto T; Taniguchi R; Nishio Y; Kita T; Fujiwara H; Takatsu Y
    Med Sci Monit; 2006 Nov; 12(11):RA252-64. PubMed ID: 17072279
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.
    Antonini-Canterin F; Popescu BA; Popescu AC; Beladan CC; Korcova R; Piazza R; Cappelletti P; Rubin D; Cassin M; Faggiano P; Nicolosi GL
    Int J Cardiol; 2008 Aug; 128(3):406-12. PubMed ID: 17662495
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
    Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acute heart failure: How to evaluate left ventricular filling pressure in practice?
    Jondeau G; Detaint D; Arnoult F; Phan G; Morgan C; Mercadier JJ; Aumont MC
    Arch Cardiovasc Dis; 2009 Apr; 102(4):319-26. PubMed ID: 19427609
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [What about the European guidelines?].
    Cohen Solal A
    Rev Prat; 2010 Sep; 60(7):938-9. PubMed ID: 21033490
    [No Abstract]   [Full Text] [Related]  

  • 71. New diagnostic modalities in the diagnosis of heart failure.
    Mitchell JE; Palta S
    J Natl Med Assoc; 2004 Nov; 96(11):1424-30. PubMed ID: 15586645
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
    Januzzi JL; Maisel AS
    Circulation; 2004 Jun; 109(25):e325-6; author reply e325-6. PubMed ID: 15226236
    [No Abstract]   [Full Text] [Related]  

  • 73. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure.
    Nishikimi T; Matsuoka H
    Circulation; 2004 Jun; 109(25):e325-6; author reply e325-6. PubMed ID: 15232833
    [No Abstract]   [Full Text] [Related]  

  • 74. Assessing prognosis in heart failure: is hepatocyte growth factor the next B-type natriuretic peptide?
    Katz JN; Drazner MH
    Am Heart J; 2005 Jul; 150(1):1-3. PubMed ID: 16084142
    [No Abstract]   [Full Text] [Related]  

  • 75. B-type natriuretic peptide: time to incorporate natriuretic peptides in our practice.
    Daniels LB; Maisel A
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):414-5. PubMed ID: 16721203
    [No Abstract]   [Full Text] [Related]  

  • 76. Brain natriuretic peptide in heart failure: an improving prognosis?
    Crook D; Smith H
    Eur Heart J; 2005 Jun; 26(11):1052-3. PubMed ID: 15800016
    [No Abstract]   [Full Text] [Related]  

  • 77. [Brain natriuretic peptide for postoperative monitoring of the fluid balance in a cardiac surgery patient].
    Publig T; Kepka A; Hermann K; Oczenski W; Mlczoch J; Schwarz S; Fitzgerald RD
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Jun; 40(6):358-60. PubMed ID: 15942856
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Molecular and clinical aspects of heart failure therapy.
    Niebauer J
    Heart Fail Monit; 2005; 4(4):114-5. PubMed ID: 16234897
    [No Abstract]   [Full Text] [Related]  

  • 79. Biochemical markers in heart failure.
    Sato Y; Fujiwara H; Takatsu Y
    J Cardiol; 2012 Jan; 59(1):1-7. PubMed ID: 22138007
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Congestion is an important diagnostic and therapeutic target in heart failure.
    Gheorghiade M; Shin DD; Thomas TO; Brandimarte F; Fonarow GC; Abraham WT
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S12-24. PubMed ID: 16955056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.